A cerebrospinal fluid blood–brain barrier dysfunction score is associated with progression from mild cognitive impairment to Alzheimer's disease

Jing Yang

Aug 2026 · Neurological Sciences · Vol 47 · 0 citations · 31 references

Medicine

TL;DR

A BBB permeability-related score is associated with longitudinal progression from mild cognitive impairment to clinically diagnosed AD dementia; CD226 is a biologically supported candidate signal; GFRα-1 is hypothesis-generating pending replication.

DOI PubMed Semantic Scholar

View source

Similar papers

Sep 2026

CSF neuroinflammatory biomarkers are associated with amyloid-β42/40, tau pathology, and cognitive impairment across the Alzheimer’s disease spectrum

Higher CSF neuroinflammatory biomarkers may be linked to AD pathology and cognitive impairment; however, given the observational design, causality cannot be established, and longitudinal mechanistic studies are needed to validate these findings.

Mubarak Alruwaili, A. Turkistani, S. Shilbayeh et al. · Immunologic research · 0 citations

Open access Jul 2026

Linking cognitive variability and Alzheimer's disease biomarkers by neurocognitive status

This study aimed to assess intra‐individual cognitive variability (IICV) in relation to Alzheimer's disease (AD) biomarkers.

S. S. Lin, Alicia L. Milam, Andrew Kiselica et al. · Alzheimer's & Dementia · 0 citations

Open access Sep 2026

Neutrophil-to-lymphocyte ratio predicts early cognitive decline associated with tau pathology in Alzheimer’s disease: a longitudinal study of the ADNI cohort

Elevated NLR was significantly and independently associated with accelerated decline across multiple cognitive domains and an increased risk of clinical progression in older adults at risk for AD and a potential role for peripheral immune dysregulation in early disease trajectories is observed.

Xin Wang, Xiao-Lei Liu, Zhi-Gang Wang et al. · Frontiers in Aging Neuroscie... · 0 citations

Aug 2026

Prognostic significance of cerebrospinal fluid tau biomarkers in amyloid-negative A−T + N + neurodegeneration: A retrospective cohort study

CSF tTau was associated with mortality and faster clinical progression, but the joint-model findings involving tTau and pTau should be interpreted cautiously as hypothesis-generating.

Aslı Aksoy Gündoğdu, B. Samancı, M. Alaylıoğlu et al. · Journal of Alzheimer's Disea... · 0 citations

Sep 2026

Associations of peripheral inflammation with hippocampal atrophy in Alzheimer's disease.

A link between systemic inflammatory burden and hippocampal vulnerability is supported, while relationships with AD pathology and clinical progression warrant further investigation.

Hong-Sheng Xie, Yu-Hao Li, Ruo-Qiu Gan et al. · Progress in Neuro-psychophar... · 0 citations

Open access Aug 2026

CSF complement proteins are associated with early tau pathology and synaptic damage in an asymptomatic population at risk of Alzheimer’s disease

Findings identify complement dysregulation, especially involving C1q, as an early correlate of tau-linked synaptic pathology, and support a role for complement activation in the AD molecular cascade.

J. Loncke, M. Savard, C. Picard et al. · bioRxiv · 0 citations